Global Reporting
With increasing transparency requirements worldwide, and the different data privacy guidelines across the globe, Global transparency reporting brings with it new challenges in the compliance world. Vector health is set to tackle these challenges head on with its legal aids from varying countries and a variety of global transparency experience on its journey to create Global Transparency 2.0!
European Region
United Kingdom
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Russian Federation
Explore More
Russian Federation
Authority (PHARMA) AIPM | Due Date:
Annually, within 6 months after the reporting period.
Authority(DEVICE) IMEDA/MedTech | Due Date:
Yearly, no later than 6 months after the end of the relevant reporting period.
Italy
Explore More
Italy
Authority (PHARMA) Farmaindustria | Due Date:
Annually, within first six months of the year after the expenses were incurred.
Authority(DEVICE) CDM/MedTech | Due Date:
Members to publish the ToVs made each yr within the first 6 months of the next yr.
Cyprus
Explore More
Cyprus
Authority (PHARMA) KEFEA| Due Date:
Within 6 months after the reporting period
Authority (DEVICE) SAIEEK/MedTech | Due Date:
Within 6 months after the reporting period
Greece
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Denmark
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
France
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Turkey
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Germany
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Austria
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Croatia
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Spain
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Switzerland
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Ukraine
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Belgium
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Bosnia
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Bulgaria
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Czech Republic
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Estonia
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Finland
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Hungary
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Iceland
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Ireland
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Latvia
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Lithuania
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Luxembourg
Explore More
Russian Federation
Authority (PHARMA) AIPM | Due Date:
Annually, within 6 months after the reporting period.
Authority(DEVICE) IMEDA/MedTech | Due Date:
Yearly, no later than 6 months after the end of the relevant reporting period.
Malta
Explore More
Italy
Authority (PHARMA) Farmaindustria | Due Date:
Annually, within first six months of the year after the expenses were incurred.
Authority(DEVICE) CDM/MedTech | Due Date:
Members to publish the ToVs made each yr within the first 6 months of the next yr.
Norway
Explore More
Cyprus
Authority (PHARMA) KEFEA| Due Date:
Within 6 months after the reporting period
Authority (DEVICE) SAIEEK/MedTech | Due Date:
Within 6 months after the reporting period
Romania
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Portugal
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Poland
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Serbia
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Slovakia
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Slovenia
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Sweden
Explore More
United Kingdom
Authority (PHARMA) ABPI | Due Date:
Submission is required by the last working day in March for publication by the end of June
Authority (DEVICE) ABHI/MedTech | Due Date:
Annually within 6 months after the end of the relevant reporting period
Middle East-Africa Region
Israel
Explore More
Israel
Authority:
Ministry of Health
Due Date:
Yearly, by first of March
Saudi Arabia
Explore More
Saudi Arabia
Authority:
Saudi Food and Drug Authority
Due Date:
Quarterly: due end of quarter
MecoMed (DEVICE)
Explore More
MecoMed (DEVICE)
Authority:
*Mecomed
Due Date:
Annually, not later than 6 months after the end of the reporting period. Each reporting period covers full calendar year, starting on 1 January and ending 31 December.
Asia-Pacific Region
Australia
Explore More
Australia
Authority (PHARMA & DEVICES):
Medicines Australia
Due Date:
31 August and 28 February
New Zealand
Explore More
New Zealand
Authority (PHARMA & DEVICES):
Medicines New Zealand
Due Date:
June 30
Japan
Explore More
Japan
Authority(PHARMA) JPMA | Due Date:
The payments in each fiscal year shall be disclosed in the following fiscal year.
Authority(DEVICE) JFDMA | Due Date:
No set due date, but during the company’s following fiscal year.
South Korea
Explore More
South Korea
Authority (PHARMA & DEVICE):
Ministry of Health and Welfare
Due Date:
Within three months after the end of the company’s fiscal year
Indonesia
Explore More
Indonesia
Authority (PHARMA & DEVICE):
Ministry of Health
Due Date:
Within 30 days after the HCP/HCO receives the support
Philippines
Explore More
Philippines
Authority (PHARMA & DEVICE):
Department of Health, through the Office of the Secretary and the FDA
Due Date:
Notice of Meetings: one moth prior to the event
Americas Region
United States of America
Explore More
United States of America
Authority (PHARMA & DEVICE):
Centers for Medicare & Medicaid Services
Due Date:
31 March
Colombia
Explore More
Colombia
Authority (PHARMA & DEVICE):
Ministry of Health and Social Protection
Due Date:
Semi-annually: before September, and before April
Canada (Ontario)
Explore More
Canada (Ontario)
Authority (PHARMA & DEVICE):
Ministry of Health
Due Date:
End of June
Brazil
Explore More
Brazil
Authority (PHARMA & DEVICE):
State Secretary of Health of Minas Gerais
Due Date:
Annually on the last business day of January for the previous calendar year’s data
Canada
Explore More
Canada
Authority (PHARMA & DEVICE):
Innovative Medicines Canada
Due Date:
Voluntary (‘regularly’)